Plasma endocannabinoids in cocaine dependence and their interaction with cocaine craving and metabotropic glutamate receptor 5 density in the human brain
Authors:
- Sara L. KrollSKSara L. Kroll
- Lea M. HulkaLHLea M. Hulka
- Ann-Kathrin KexelAKAnn-Kathrin Kexel
- Katrin H. PrellerKPKatrin H. Preller
- Valerie TreyerVTValerie Treyer
- Markus R. BaumgartnerMBMarkus R. Baumgartner
- Franziska PahlischFPFranziska Pahlisch
- Cathrin RohlederCRCathrin Rohleder
- F. Markus LewekeFLF. Markus Leweke
Preprint
Abstract
Animal models indicate that the endocannabinoid system (ECS) plays a modulatory role in stress and reward processing, both crucially impaired in addictive disorders. Preclinical findings showed endocannabinoid-modulated synaptic plasticity in reward brain networks linked to the metabotropic-glutamate-5 receptor (mGluR5), contributing to drug-reinforcing effects and drug-seeking behavior. Although animal models postulate a link between ECS and cocaine addiction, human translational studies are lacking. Here, we tested previous preclinical findings by investigating plasma endocannabinoids (eCBs) anandamide (AEA), 2-arachidonoylglycerol (2-AG), and the related N-acylethanolamines (NAEs) palmitoylethanolamide (PEA) and oleoylethanolamide (OEA), including their interaction with cerebral mGluR5, in chronic cocaine users (CU). We compared basal plasma concentrations between chronic CU (N=103; 69 recreational CU and 34 dependent CU) and stimulant-naïve healthy controls (N=92). Follow-up basal eCB/NAE plasma levels after 12 months were used for reliability and stability check (CU: N=33; controls: N=43). In an additional analysis using 11 C-ABP688 positron emission tomography (PET) in a male subsample (CU: N=18; controls: N=16), we investigated the relationships between eCBs/NAEs and mGluR5 density in the brain. We found higher 2-AG plasma levels in dependent CU compared to controls and recreational CU. 2-AG levels were stable over time across all groups. In the PET-subsample, a positive association between 2-AG and mGluR5 brain density only in CU was found. Our results corroborate animal findings suggesting an alteration of the ECS in cocaine dependence and an association between peripheral 2-AG levels and cerebral mGluR5 in humans. Therefore, the ECS might be a promising pharmaco-therapeutic target for novel treatments of cocaine dependence.Keywords
This publication has 77 references indexed in Scilit:
- Imaging Dopamine Transmission in Cocaine Dependence: Link Between Neurochemistry and Response to TreatmentAmerican Journal of Psychiatry, 2011
- Drug-Evoked Synaptic Plasticity in Addiction: From Molecular Changes to Circuit RemodelingNeuron, 2011
- Mesocorticolimbic circuits are impaired in chronic cocaine users as demonstrated by resting-state functional connectivityNeuroImage, 2010
- Evaluation of a bolus/infusion protocol for 11C-ABP688, a PET tracer for mGluR5Nuclear Medicine and Biology, 2010
- Neuroplasticity in the mesolimbic dopamine system and cocaine addictionBritish Journal of Pharmacology, 2008
- A Comprehensive Profile of Brain Enzymes that Hydrolyze the Endocannabinoid 2-ArachidonoylglycerolChemistry & Biology, 2007
- High opiate receptor binding potential in the human lateral pain systemNeuroImage, 2006
- The neuroscience of addictionNature Neuroscience, 2005
- A SingleIn VivoExposure to Cocaine Abolishes Endocannabinoid-Mediated Long-Term Depression in the Nucleus AccumbensJournal of Neuroscience, 2004
- Food reward and cocaine increase extracellular dopamine in the nucleus accumbens as measured by microdialysisLife Sciences, 1988